{
  "ptid_time": "027_S_5127_2014-04-30",
  "img_path": "/data/qiuhui/data/adni/images/027_S_5127/2014-04-30/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 69,646 mm³, 148.1% above the reference mean. With a Z-score of 3.39 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 7,844 mm³, 10.3% above the reference mean. With a Z-score of 0.94 (82.6th percentile), this represents normal volume ; whole brain volume measures 1,023,800 mm³, 5.0% above the reference mean. With a Z-score of 0.63 (73.7th percentile), this represents normal volume ; entorhinal cortex volume measures 3,171 mm³, 13.7% below the reference mean. With a Z-score of -0.84 (20.1th percentile), this represents normal volume ; fusiform gyrus volume measures 18,197 mm³, 7.0% above the reference mean. With a Z-score of 0.63 (73.7th percentile), this represents normal volume ; middle temporal gyrus volume measures 21,770 mm³, 13.6% above the reference mean. With a Z-score of 1.18 (88.1th percentile), this represents mild enlargement. ",
  "text_data": "Age is 77.3 years. Gender is Female. Education: 19 years. MMSE: 30.0. MoCA: 29.0. Logical Memory: 11.0. APOEε4 alleles: 1.0. ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound ventricular enlargement (148.1% above reference, Z-score 3.39), which is strongly associated with neurodegeneration, while hippocampal and whole brain volumes are normal. Cognitive scores (MMSE 30, MoCA 29) are intact, but ventricular enlargement raises concern for early neurodegenerative changes despite normal cognition.  \n\n**Diagnosis:** **Cognitively Normal (CN)** with biomarker evidence of possible preclinical Alzheimer’s pathology (ventricular enlargement).  \n\n**Confidence:** **Medium** (normal cognition but significant structural change; APOE4 carrier status adds risk but not yet clinical impairment).  \n\n*Note: Ventricular enlargement is a sensitive marker of atrophy, but without cognitive decline, this aligns more with preclinical AD than MCI/dementia. Follow-up monitoring is warranted.*",
  "timestamp": "2025-07-26T04:09:55.658695"
}